Cargando…
Rapid Infusion Rituximab for Maintenance Therapy: Is It Feasible?
Rituximab is an anti-CD-20 monoclonal antibody used in the management of lymphoproliferative disorders. The use of maintenance rituximab has improved progression free survival and overall survival in follicular lymphomas. Although rapid rituximab infusions have been studied extensively, there is lit...
Autores principales: | Patel, Jolly, Ho, Melissa, Ho, Viet, Bello, Celeste, Djulbegovic, Benjamin, Sokol, Lubomir, Wetzstein, Gene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833187/ https://www.ncbi.nlm.nih.gov/pubmed/24288618 http://dx.doi.org/10.1155/2013/629283 |
Ejemplares similares
-
Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan
por: Yokoyama, Masahiro, et al.
Publicado: (2013) -
Hematological Malignancies and Arterial Thromboembolism
por: Visweshwar, Nathan, et al.
Publicado: (2019) -
Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020) -
Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma
por: Modelevsky, Lisa, et al.
Publicado: (2018) -
Rituximab maintenance therapy of follicular lymphoma in clinical practice
por: Dührsen, Ulrich, et al.
Publicado: (2018)